Roche Hldg Sp ADR (RHHBY)
$40.02
0.00 (0.00%)
RHHBY Stock Quote Delayed 30 Minutes
Hot Stocks: The 3 Best Opportunities for Investing in Weight Loss Drugs
The market for weight loss drug stocks is massive, and these three companies could be the biggest beneficiaries of this trend.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$39.37
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
3.87M
Day's Range
$40.02 - $40.90
52-Week Range
$28.29 - $42.93
Dividend & Yield
$1.36 (3.41%)
RHHBY Stock Predictions, Articles, and Roche Hldg Sp ADR News
Roche Stock Rallies on Promising Coronavirus Drug Results
Roche stock is rallying Friday on news that Actemra, an anti-inflammatory drug from the Swiss company, may help coronavirus patients.
Roche Holding News: RHHBY Stock Jumps 8% on Faster Coronavirus Test
Roche Holding (RHHBY) news for Friday includes an update on testing for the coronavirus from China with approval from the FDA.
The Roche Merger Will Do Wonders for Spark Stock
As Spark Therapeutics gets acquired, existing shareholders, and Roche investors, will need to eveluate the merits of the deal.
Why NOW Is the Time to Buy Gene Therapy Stocks
Over the long term, gene therapy stocks will head higher and the last few weeks' of headlines show investors why.
ONCE Stock: Roche Buy Sends Spark Therapeutics Shares Soaring
Spark Therapeutics (ONCE) stock was flying high Monday on news of a deal that will have it being bought for $114.50 per share.
Why Spark Therapeutics Stock Is Getting Slammed Today
Spark Therapeutics (ONCE) stock was falling hard on Tuesday following the release of its earnings report for the second quarter of 2018.
Stocks May Bring Volatility for the Holidays
Stocks continue to grow more overbought, while the Bitcoin craze continues. Here's what investors need to know about the market today.
3 Stocks to Watch on Friday: Baxter International Inc (BAX), Exfo Inc (EXFO) and Spark Therapeutics Inc (ONCE)
Baxter International (BAX) outlook down, Exfo (EXFO) earnings impress and Spark Therapeutics' (ONCE) blindness drug may be approved.
Why NewLink Genetics Corp (NLNK), Urban Outfitters, Inc. (URBN) and Dell Technologies Inc (DVMT) Are 3 of Today’s Worst Stocks
Dell Technologies (DVMT), NewLink Genetics (NLNK) and Urban Outfitters (URBN) shareholders couldn't wait for Thursday's action to come to a close.
3 Cheap Biotech Stocks The Big Boys Are Buying (BLRX, OMED, FWP)
Biotechnology is among the most exciting and lucrative sectors for investors, and these 3 biotech stocks stand out...
iShares MSCI EAFE Index Fund (ETF) (EFA): The Quick Guide to EFA
The iShares MSCI EAFE ETF (EFA) holds nearly 940 stocks based outside the U.S. Is the EFA the right way to get international exposure?
